Spotlight Growth
No Result
View All Result
Monday, July 4, 2022
  • Login
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Cryptocurrency

Ethereum Classic (ETC) Has Soared Around 78% Recently, But its Past Vulnerabilities Remain

by admin
March 29, 2022
in Cryptocurrency
0
Ethereum Classic ETC March 2022 Spotlight Growth

Ethereum Classic ETC March 2022 Spotlight Growth

As Bitcoin once again shows signs of life, alternative cryptocurrencies are beginning to move. Perhaps the most confusing of the lot is Ethereum Classic, the well-known hard-fork of Ethereum’s core blockchain. Ethereum Classic has seen its coin price soar from around $28 to over $50, or around 78.5%, in just 11 days between March 18th and March 29th. ETC spiking is nothing new – the lower volume and liquidity make the off-shoot more prone to volatility – but it does show a long-term memory problem within the industry. Ostensibly, Ethereum Classic exists to honor the “decentralized” idea of code-as-law.

A closer look shows that ETC’s creation came from a misguided attempt to hold the blockchain responsible for a major hack. Beyond this, Ethereum Classic proved itself more prone to hacking than the core chain, serving as one of the few high-profile examples of a successful 51% attack. Investors that continue to insist on sinking money into ETC either lack any knowledge of these events or lack any degree of self-preservation.

The History of Ethereum Classic

Ethereum Classic came about because of the failure of the first DAO. The original Decentralized Autonomous Organization served as a decentralized venture-capital firm and ultimately suffered from a multi-million dollar hack. In the aftermath, the Ethereum community – supported by major players like Vitalik Buterin – chose to roll back the chain and undo the hack.

Ethereum Classic; Source: CoinMarketCap
Ethereum Classic; Source: CoinMarketCap

This did not sit well with a small subset of the community, who hard forked the blockchain and created Ethereum Classic. At the time, the cryptocurrency industry featured dozens of “Bitcoin” derivative projects, so this did not appear strange. Yet, Ethereum Classic soon ran into problems of its own. Ironically, the 51% attacks that plague the ETC blockchain alter transaction data – precisely the reason they forked from Ethereum in the first place.

Driving the Argument for Investor Protections

The cryptocurrency market exemplifies a financial libertarian mindset of complete investing freedom. Unfortunately for proponents of this type of market, investors often prove incapable of doing the bare minimum to protect themselves. Investing in Ethereum Classic after repeated 51% attacks and a history of underperforming shows that some form of regulation may be needed – if only to enforce a knowledge of the industry’s history.

As is, there is nothing to stop investors from buying Ethereum Classic – nor is there anything to suggest that the blockchain suffers from persistent issues. ETC’s frequent spikes in value simply prove that most investors are unwilling to perform even the most cursory of research, something that does not bode well for the market moving forward.

Tags: binanceBitcoinblockchainblockchain newscoinbasecoinmarketcapcryptocrypto tradingCryptocurrencycryptocurrency newscryptonewsdigital currencyemerging growthETCETC newsETC priceeth vs etcEthereumEthereum Classicethereum classic newsFTXinvestinginvestmentnewsSpotlight Growthtechtrading
Plugin Install : Widget Tab Post needs JNews - View Counter to be installed
  • Trending
  • Comments
  • Latest
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

November 22, 2021
Alfi NASDAQ ALF Ridesharing Tablet Rollout Spotlight Growth

Alfi, Inc. (NASDAQ: ALF) Climbs 51% After Entering Into Agreement with Miami-Based Fulfillment & Distribution Center For its Ridesharing Digital Tablet Rollout

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Emergent Health OTC EMGE LOI Fusion Specialty Pharmacy Spotlight Growth

Emergent Health Corp. (OTC Pink: EMGE) Announces LOI to Acquire Fusion Specialty Pharmacy

June 29, 2022
Decibel Therapeutics NASDAQ DBTX Interim Data Phase 1b DB 020 Spotlight Growth

Decibel Therapeutics (NASDAQ: DBTX) Shares Positive Interim Data of its Ongoing Phase 1b Trial of DB-020

June 28, 2022
Ayurcann CSE AYUR OTCQB AYURF July Product Rollout Canada Spotlight Growth

Ayurcann (CSE: AYUR) (OTCQB: AYURF) Prepares for July New Product Rollout as Distribution Expansion Continues Across Canada

June 27, 2022
NeuroSense Therapeutics NASDAQ NRSN Stage III ALS Biomarker Study Spotlight Growth

NeuroSense Therapeutics (NASDAQ: NRSN) Details PrimeC’s Positive Results from Stage III ALS Biomarker Study

June 27, 2022

Recent News

Emergent Health OTC EMGE LOI Fusion Specialty Pharmacy Spotlight Growth

Emergent Health Corp. (OTC Pink: EMGE) Announces LOI to Acquire Fusion Specialty Pharmacy

June 29, 2022
Decibel Therapeutics NASDAQ DBTX Interim Data Phase 1b DB 020 Spotlight Growth

Decibel Therapeutics (NASDAQ: DBTX) Shares Positive Interim Data of its Ongoing Phase 1b Trial of DB-020

June 28, 2022

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us
Spotlight Growth

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested